DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Antiemetic Drugs Market Analysis: By Type of Drug (5-HT3 receptor antagonists, Dopamine antagonists, Steroid-Corticosteroids, Benzodiazepines, NK1 receptor antagonist, Antihistamines, Cannabinoids); By Applications With Forecast (2016-2021)" report to their offering.
Antiemetic drugs are those that have the ability to treat conditions such as nausea and vomiting. They can be used to treat the aforementioned conditions caused by a range of illnesses. Chemotherapy for cancer patients, food poisoning, gastroenteritis, motion sickness and so on can be treated by antiemetic drugs. In case of pregnant women, these drugs bring significant relief to women who have to endure bouts of morning sickness, either during the early phase of the pregnancy. For some women, the morning sickness lasts for much longer and antiemetic drugs are extremely useful in such situations.
Increasing number of people being affected with different types of cancer is another factor driving the growth of the antiemetic drug market. Chemotherapy is one of the standard treatments used to deal with cancer and is also accompanied by side effects of nausea and vomitting. In fact, chemotherapy actually accounts for the largest share of all the applications of the global antiemetic drugs market.
The following are just a few of the companies that are operating in the Antiemetic Drugs market:
- Baxter International
- Novartis AG
- Johnson and Johnson
- GlaxoSmithKline Plc
- Cipla Ltd.
1. Antiemetic Drugs Market Overview
2. Executive Summary
3. Antiemetic Drugs Market Landscape
4. Antiemetic Drugs Market Forces
5. Antiemetic Drugs Market - Strategic Analysis
6. Antiemetic Drugs Market By Type of Drug
7. Antiemetic Drugs Market By Application
8. Antiemetic Drugs Market By Geography
9. Antiemetic Drugs Market Entropy
10. Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/nlsxfz/antiemetic_drugs